BACKGROUNDMore than 20 years ago, it was hypothesized that exposure to prenatal and early
postnatal environmental xenobiotics with the potential to disrupt endogenous
hormone signaling might be on the causal path to cryptorchidism, hypospadias, low
sperm count and testicular cancer. Several consensus statements and narrative
reviews in recent years have divided the scientific community and have elicited a
call for systematic transparent reviews. We aimed to fill this gap in knowledge in
the field of male reproductive disorders.OBJECTIVE AND RATIONALEThe aim of this study was to systematically synthesize published data on the risk
of cryptorchidism, hypospadias, low sperm counts and testicular cancer following
in utero or infant exposure to chemicals that have been
included on the European Commission's list of Category 1 endocrine
disrupting chemicals defined as having documented adverse effects due to endocrine
disruption in at least one intact organism.SEARCH METHODSA systematic literature search for original peer reviewed papers was performed in
the databases PubMed and Embase to identify epidemiological studies reporting
associations between the outcomes of interest and exposures documented by
biochemical analyses of biospecimens including maternal blood or urine, placenta
or fat tissue as well as amnion fluid, cord blood or breast milk; this was
followed by meta-analysis of quantitative data.OUTCOMESThe literature search resulted in 1314 references among which we identified 33
papers(28 study populations) fulfilling the eligibility criteria. These provided
85 risk estimates of links between persistent organic pollutants and rapidly
metabolized compounds (phthalates and Bisphenol A) and male reproductive
disorders. The overall odds ratio (OR) across all exposures and outcomes was 1.11
(95% CI 0.91–1.35). When assessing four specific chemical subgroups
with sufficient data for meta-analysis for all outcomes, we found that exposure to
one of the four compounds, p,p′-DDE, was related to an elevated risk: OR
1.35 (95% CI 1.04–1.74). The data did not indicate that this
increased risk was driven by any specific disorder.WIDER IMPLICATIONSThe current epidemiological evidence is compatible with a small increased risk of
male reproductive disorders following prenatal and postnatal exposure to some
persistent environmental chemicals classified as endocrine disruptors but the
evidence is limited. Future epidemiological studies may change the weight of the
evidence in either direction. No evidence of distortion due to publication bias
was found, but exposure–response relationships are not evident. There are
insufficient data on rapidly metabolized endocrine disruptors and on specific
exposure–outcome relations. A particular data gap is evident with respect
to delayed effects on semen quality and testicular cancer. Although high quality
epidemiological studies are still sparse, future systematic and transparent
reviews may provide pieces of evidence contributing to the narrative and weight of
the evidence assessments in th...